Literature DB >> 12480310

Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.

B Evrard1, P Chiap, P DeTullio, F Ghalmi, G Piel, T Van Hees, J Crommen, B Losson, L Delattre.   

Abstract

Albendazole (ABZ) is a benzimidazole derivative with a broad spectrum of activity against human and animal helminthe parasites. ABZ has a very poor aqueous solubility. This study shows that hydroxypropyl-beta-cyclodextrin (HP-beta-CD) is able to form inclusion complexes with ABZ and that is able to increase its aqueous solubility. A synergistic effect exists between HP-beta-CD and citric acid. The combination of HP-beta-CD (200 mM) and citric acid (50 mM) allows dissolution of more than 1.5 mg of ABZ per ml. The aim of this study is the in vivo evaluation in sheep of a solution of the inclusion complex of ABZ with HP-beta-CD in comparison with a suspension of the same drug. A significant (P<0.05) increase in the relative bioavailability is obtained with the solution containing the ABZ-HP-beta-CD complex as measured by ABZSO plasma levels. The area under the curve (AUC(0--> proportional, variant )) of the solution is 37% higher than that obtained with the suspension. Likewise the peak plasma concentration (C(max)) is twice that of the solution while the time to reach C(max) (T(max)) is reduced.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480310     DOI: 10.1016/s0168-3659(02)00270-5

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.

Authors:  Laura Ceballos; Celina Elissondo; Sergio Sánchez Bruni; Guillermo Denegri; Carlos Lanusse; Luis Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.

Authors:  P A Pacheco; L N C Rodrigues; J F S Ferreira; A C P Gomes; C J Veríssimo; H Louvandini; R L D Costa; L M Katiki
Journal:  Parasitol Res       Date:  2018-01-11       Impact factor: 2.289

3.  Improved albendazole dissolution rate in pluronic 188 solid dispersions.

Authors:  Silvina G Castro; Sergio Sanchez Bruni; Carlos E Lanusse; Daniel A Allemandi; Santiago D Palma
Journal:  AAPS PharmSciTech       Date:  2010-10-14       Impact factor: 3.246

4.  Biodegradable Elastomers with Antioxidant and Retinoid-like Properties.

Authors:  Robert van Lith; Xuesong Wang; Guillermo Ameer
Journal:  ACS Biomater Sci Eng       Date:  2016-01-06

5.  Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.

Authors:  Laura Ceballos; Celina Elissondo; Laura Moreno; Marcela Dopchiz; Sergio Sánchez Bruni; Guillermo Denegri; Luis Alvarez; Carlos Lanusse
Journal:  Parasitol Res       Date:  2008-05-10       Impact factor: 2.289

6.  Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers.

Authors:  I M Rigter; H G Schipper; R P Koopmans; H J M van Kan; H W Frijlink; P A Kager; H-J Guchelaar
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

7.  Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.

Authors:  Laura Ceballos; Laura Moreno; Juan J Torrado; Carlos Lanusse; Luis Alvarez
Journal:  BMC Vet Res       Date:  2012-05-28       Impact factor: 2.741

8.  Cyclodextrins in delivery systems: Applications.

Authors:  Gaurav Tiwari; Ruchi Tiwari; Awani K Rai
Journal:  J Pharm Bioallied Sci       Date:  2010-04

9.  Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis.

Authors:  Jean Rodgers; Amy Jones; Stéphane Gibaud; Barbara Bradley; Christopher McCabe; Michael P Barrett; George Gettinby; Peter G E Kennedy
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

10.  Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule.

Authors:  L Ceballos; L Alvarez; C Mackenzie; T Geary; C Lanusse
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-09-25       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.